4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001140361-24-050413
President sold 4,000 shares at an average $12.10 ($48,399)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ma Songjiang · President
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-23 | Sale : show line 1 in the form 10b5-1 | −1,704 | $12.24 | $20,857 | 2,932,763 | I |
| 2024-12-23 | Sale : show line 2 in the form 10b5-1 | −296 | $12.44 | $3,682 | 2,932,467 | I |
| 2024-12-24 | Sale : show line 3 in the form 10b5-1 | −2,000 | $11.93 | $23,860 | 2,930,467 | I |
| Open-market sales · 4,000 sh · avg $12.10 · $48,399 | ||||||
Loading xslF345X05/form4.xml…